Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Design considerations for characterizing psychiatric trajectories across the lifespan: application to effects of APOE-ε4 on cerebral cortical thickness in Alzheimer's disease.

Thompson WK, Hallmayer J, O'Hara R; Alzheimer's Disease Neuroimaging Initiative..

Am J Psychiatry. 2011 Sep;168(9):894-903. doi: 10.1176/appi.ajp.2011.10111690. Epub 2011 Jul 1. Review.

PMID:
21724665
2.

Family history of Alzheimer's disease and hippocampal structure in healthy people.

Donix M, Burggren AC, Suthana NA, Siddarth P, Ekstrom AD, Krupa AK, Jones M, Martin-Harris L, Ercoli LM, Miller KJ, Small GW, Bookheimer SY.

Am J Psychiatry. 2010 Nov;167(11):1399-406. doi: 10.1176/appi.ajp.2010.09111575. Epub 2010 Aug 4.

3.

APOE associated hemispheric asymmetry of entorhinal cortical thickness in aging and Alzheimer's disease.

Donix M, Burggren AC, Scharf M, Marschner K, Suthana NA, Siddarth P, Krupa AK, Jones M, Martin-Harris L, Ercoli LM, Miller KJ, Werner A, von Kummer R, Sauer C, Small GW, Holthoff VA, Bookheimer SY.

Psychiatry Res. 2013 Dec 30;214(3):212-20. doi: 10.1016/j.pscychresns.2013.09.006. Epub 2013 Sep 27.

4.

Longitudinal changes in medial temporal cortical thickness in normal subjects with the APOE-4 polymorphism.

Donix M, Burggren AC, Suthana NA, Siddarth P, Ekstrom AD, Krupa AK, Jones M, Rao A, Martin-Harris L, Ercoli LM, Miller KJ, Small GW, Bookheimer SY.

Neuroimage. 2010 Oct 15;53(1):37-43. doi: 10.1016/j.neuroimage.2010.06.009. Epub 2010 Jun 10.

5.

Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E epsilon4 allele.

Juottonen K, Lehtovirta M, Helisalmi S, Riekkinen PJ Sr, Soininen H.

J Neurol Neurosurg Psychiatry. 1998 Sep;65(3):322-7.

6.

Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study.

Liu Y, Paajanen T, Westman E, Wahlund LO, Simmons A, Tunnard C, Sobow T, Proitsi P, Powell J, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Evans A, Spenger C, Lovestone S, Soininen H; AddNeuroMed Consortium..

J Alzheimers Dis. 2010;21(3):947-66. doi: 10.3233/JAD-2010-100201.

PMID:
20693633
7.

Relationship of medial temporal lobe atrophy, APOE genotype, and cognitive reserve in preclinical Alzheimer's disease.

Soldan A, Pettigrew C, Lu Y, Wang MC, Selnes O, Albert M, Brown T, Ratnanather JT, Younes L, Miller MI; BIOCARD Research Team..

Hum Brain Mapp. 2015 Jul;36(7):2826-41. doi: 10.1002/hbm.22810. Epub 2015 Apr 16.

8.

Patterns of cortical thickness according to APOE genotype in Alzheimer's disease.

Gutiérrez-Galve L, Lehmann M, Hobbs NZ, Clarkson MJ, Ridgway GR, Crutch S, Ourselin S, Schott JM, Fox NC, Barnes J.

Dement Geriatr Cogn Disord. 2009;28(5):476-85. doi: 10.1159/000258100. Epub 2009 Nov 26.

PMID:
19940480
9.

Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates.

Chen K, Reiman EM, Alexander GE, Caselli RJ, Gerkin R, Bandy D, Domb A, Osborne D, Fox N, Crum WR, Saunders AM, Hardy J.

Am J Psychiatry. 2007 Jun;164(6):916-21.

PMID:
17541051
10.

APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging.

Thambisetty M, Beason-Held L, An Y, Kraut MA, Resnick SM.

Arch Neurol. 2010 Jan;67(1):93-8. doi: 10.1001/archneurol.2009.913.

11.

Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease.

Mormino EC, Betensky RA, Hedden T, Schultz AP, Ward A, Huijbers W, Rentz DM, Johnson KA, Sperling RA; Alzheimer's Disease Neuroimaging Initiative.; Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing.; Harvard Aging Brain Study..

Neurology. 2014 May 20;82(20):1760-7. doi: 10.1212/WNL.0000000000000431. Epub 2014 Apr 18.

12.

Genetic variation in apolipoprotein E alters regional gray matter volumes in remitted late-onset depression.

Yuan Y, Zhang Z, Bai F, You J, Yu H, Shi Y, Liu W.

J Affect Disord. 2010 Mar;121(3):273-7. doi: 10.1016/j.jad.2009.07.003. Epub 2009 Jul 31.

PMID:
19647324
13.

Longitudinal change in working memory as a function of APOE genotype in midlife and old age.

Greenwood PM, Espeseth T, Lin MK, Reinvang I, Parasuraman R.

Scand J Psychol. 2014 Jun;55(3):268-77. doi: 10.1111/sjop.12123.

14.

APOE interacts with age to modify rate of decline in cognitive and brain changes in Alzheimer's disease.

Chang YL, Fennema-Notestine C, Holland D, McEvoy LK, Stricker NH, Salmon DP, Dale AM, Bondi MW; Alzheimer's Disease Neuroimaging Initiative..

Alzheimers Dement. 2014 May;10(3):336-48. doi: 10.1016/j.jalz.2013.05.1763. Epub 2013 Jul 27.

15.

Butyrylcholinesterase K and apolipoprotein ε4 affect cortical thickness and neuropsychiatric symptoms in Alzheimer's disease.

Yoo HB, Lee HW, Shin S, Park SW, Choi JS, Jung HY, Cha J, Lee JM, Lee JY.

Curr Alzheimer Res. 2014 Feb;11(2):137-44.

PMID:
24479631
16.

Low plasma ApoE levels are associated with smaller hippocampal size in the Alzheimer's disease neuroimaging initiative cohort.

Teng E, Chow N, Hwang KS, Thompson PM, Gylys KH, Cole GM, Jack CR Jr, Shaw LM, Trojanowski JQ, Soares HD, Weiner MW, Apostolova LG; Alzheimer’s Disease Neuroimaging Initiative..

Dement Geriatr Cogn Disord. 2015;39(3-4):154-66. doi: 10.1159/000368982. Epub 2014 Dec 24.

17.

Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.

Lautner R, Palmqvist S, Mattsson N, Andreasson U, Wallin A, Pålsson E, Jakobsson J, Herukka SK, Owenius R, Olsson B, Hampel H, Rujescu D, Ewers M, Landén M, Minthon L, Blennow K, Zetterberg H, Hansson O; Alzheimer’s Disease Neuroimaging Initiative..

JAMA Psychiatry. 2014 Oct;71(10):1183-91. doi: 10.1001/jamapsychiatry.2014.1060.

PMID:
25162367
18.

Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo.

Pievani M, Rasser PE, Galluzzi S, Benussi L, Ghidoni R, Sabattoli F, Bonetti M, Binetti G, Thompson PM, Frisoni GB.

Neuroimage. 2009 May 1;45(4):1090-8. doi: 10.1016/j.neuroimage.2009.01.009. Epub 2009 Jan 21.

19.

Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease.

Wolk DA, Dickerson BC; Alzheimer's Disease Neuroimaging Initiative..

Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10256-61. doi: 10.1073/pnas.1001412107. Epub 2010 May 17.

20.

Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.

Berg L, McKeel DW Jr, Miller JP, Storandt M, Rubin EH, Morris JC, Baty J, Coats M, Norton J, Goate AM, Price JL, Gearing M, Mirra SS, Saunders AM.

Arch Neurol. 1998 Mar;55(3):326-35.

PMID:
9520006

Supplemental Content

Support Center